Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
US Army
Harvard Business School
Covington
Accenture
Mallinckrodt
Teva
Federal Trade Commission

Generated: December 10, 2018

DrugPatentWatch Database Preview

SYLVANT Drug Profile

« Back to Dashboard

Summary for Tradename: SYLVANT
Patents:9
Applicants:1
BLAs:1
Suppliers: see list1
Pharmacology for SYLVANT
Mechanism of ActionInterleukin-6 Antagonists

US Patents for SYLVANT

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Janssen Biotech SYLVANT siltuximab INJECTABLE;INJECTION 125496 002 2014-04-23 ➤ Sign Up President and Fellows of Harvard College (Cambridge, MA) ➤ Sign Up RX Orphan search
Janssen Biotech SYLVANT siltuximab INJECTABLE;INJECTION 125496 002 2014-04-23 ➤ Sign Up Corning Incorporated (Corning, NY) ➤ Sign Up RX Orphan search
Janssen Biotech SYLVANT siltuximab INJECTABLE;INJECTION 125496 002 2014-04-23 ➤ Sign Up ABBVIE STEMCENTRX LLC (North Chicago, IL) ➤ Sign Up RX Orphan search
Janssen Biotech SYLVANT siltuximab INJECTABLE;INJECTION 125496 002 2014-04-23 ➤ Sign Up Corning Incorporated (Corning, NY) ➤ Sign Up RX Orphan search
Janssen Biotech SYLVANT siltuximab INJECTABLE;INJECTION 125496 002 2014-04-23 ➤ Sign Up CureVac AG (Tubingen, DE) ➤ Sign Up RX Orphan search
Janssen Biotech SYLVANT siltuximab INJECTABLE;INJECTION 125496 002 2014-04-23 ➤ Sign Up biOasis Technologies, Inc. (Richmond, CA) ➤ Sign Up RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Teva
Dow
Covington
Johnson and Johnson
Fish and Richardson
Federal Trade Commission
Daiichi Sankyo
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.